Back to Directory Katherine Luzuriaga Email katherine.luzuriaga@umassmed.edu Institution Division of Pediatric Immunology, Infectious Diseases, and Rheumatology Title Professor and Chief Request an Update Affiliated Studies P1030: Lopinavir/Ritonavir in HIV-1 Infected Infants DAIDS Number 10041 Research Area Other Study Status Concluded P1051: Pharmacokinetic Study of Tipranavir with Ritonavir in HIV-infected Patients. DAIDS Number 10109 Research Area Other Study Status Concluded P1059: Phase I Trial of Recombinant Vaccines in HIV+ Young Adults DAIDS Number 10051 Research Area Other Study Status Concluded 1077FF: PROMISE 1077FF DAIDS Number 10778 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed P1115: Very Early Intensive Treatment of Infants Living with HIV to Achieve HIV Remission: A Phase I/II Proof of Concept Study DAIDS Number 11954 Research Area Cure and Immunotherapy Study Status Enrolling Show All
P1030: Lopinavir/Ritonavir in HIV-1 Infected Infants DAIDS Number 10041 Research Area Other Study Status Concluded
P1051: Pharmacokinetic Study of Tipranavir with Ritonavir in HIV-infected Patients. DAIDS Number 10109 Research Area Other Study Status Concluded
P1059: Phase I Trial of Recombinant Vaccines in HIV+ Young Adults DAIDS Number 10051 Research Area Other Study Status Concluded
1077FF: PROMISE 1077FF DAIDS Number 10778 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed
P1115: Very Early Intensive Treatment of Infants Living with HIV to Achieve HIV Remission: A Phase I/II Proof of Concept Study DAIDS Number 11954 Research Area Cure and Immunotherapy Study Status Enrolling
